The CORE Platform Trial | MicrobiomeTrials← Back to trialsNCT07892976
The CORE Platform Trial
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2027-01-01Est. Completion: 2044-01
Enrollment target: 15,000 participants Locations- UZ Leuven, Leuven, Belgium
- Copenhagen University Hospital - Rigshospitalet, Copenhagen, Capital Region, Denmark
- UMC Utrecht, Utrecht, Netherlands
Other microbiome trials you might be interested in
ST-Elevation Myocardial Infarction (STEMI)
The REFLOW AMI Trial aims to determine whether prophylactic high-dose intracoronary adenosine reduces slow-flow or no-re…
Lahore, PakistanEst. completion Aug 14, 2027
CABGGraft FailureColchicine
This is a single-center, prospective, randomized, open-label, assessor-blinded, blank-controlled exploratory (pilot) tri…
Shanghai, ChinaEst. completion Oct 2027
Recruiting
Coronary Artery Disease (CAD)
This study will compare the effectiveness of the TRADENT™ coronary scoring balloon with a conventional non-scoring ballo…
Multiple LocationsEst. completion Nov 30, 2027